J 2018

0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction

TWERENBOLD, R.; P. BADERTSCHER; J. BOEDDINGHAUS; T. NESTELBERGER; K. WILDI et. al.

Základní údaje

Originální název

0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction

Autoři

TWERENBOLD, R. (756 Švýcarsko); P. BADERTSCHER (756 Švýcarsko); J. BOEDDINGHAUS (756 Švýcarsko); T. NESTELBERGER (756 Švýcarsko); K. WILDI (756 Švýcarsko); C. PUELACHER (756 Švýcarsko); Z. SABTI (756 Švýcarsko); M.R. GIMENEZ (756 Švýcarsko); S. TSCHIRKY (756 Švýcarsko); J.D. de LAVALLAZ (756 Švýcarsko); N. KOZHUHAROV (756 Švýcarsko); L. SAZGARY (756 Švýcarsko); D. MUELLER (756 Švýcarsko); T. BREIDTHARDT (756 Švýcarsko); I. STREBEL (756 Švýcarsko); D.F. WIDMER (756 Švýcarsko); S. SHRESTHA (756 Švýcarsko); O. MIRO (724 Španělsko); F.J. MARTIN-SANCHEZ (724 Španělsko); B. MORAWIEC (616 Polsko); Jiří PAŘENICA (203 Česká republika, domácí); N. GEIGY (756 Švýcarsko); D.I. KELLER (756 Švýcarsko); K. RENTSCH (756 Švýcarsko); A. von ECKARDSTEIN (756 Švýcarsko); S. OSSWALD (756 Švýcarsko); T. REICHLIN (756 Švýcarsko) a C. MUELLER (756 Švýcarsko, garant)

Vydání

Circulation, Philadelphia, Lippincott Williams Wilkins, 2018, 0009-7322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 23.054

Kód RIV

RIV/00216224:14110/18:00103658

Organizační jednotka

Lékařská fakulta

UT WoS

000423565200005

EID Scopus

2-s2.0-85048400833

Klíčová slova anglicky

0/1-hour algorithm; chronic kidney disease; diagnosis of acute myocardial infarction; high-sensitivity cardiac troponin; renal dysfunction

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 2. 2019 16:08, Soňa Böhmová

Anotace

V originále

Background: The European Society of Cardiology recommends a 0/1-hour algorithm for rapid rule-out and rule-in of non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin (hs-cTn) concentrations irrespective of renal function. Because patients with renal dysfunction (RD) frequently present with increased hs-cTn concentrations even in the absence of non-ST-segment elevation myocardial infarction, concern has been raised regarding the performance of the 0/1-hour algorithm in RD. Methods: In a prospective multicenter diagnostic study enrolling unselected patients presenting with suspected non-ST-segment elevation myocardial infarction to the emergency department, we assessed the diagnostic performance of the European Society of Cardiology 0/1-hour algorithm using hs-cTnT and hs-cTnI in patients with RD, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2), and compared it to patients with normal renal function. The final diagnosis was centrally adjudicated by 2 independent cardiologists using all available information, including cardiac imaging. Safety was quantified as sensitivity in the rule-out zone, accuracy as the specificity in the rule-in zone, and efficacy as the proportion of the overall cohort assigned to either rule-out or rule-in based on the 0- and 1-hour sample. Results: Among 3254 patients, RD was present in 487 patients (15%). The prevalence of non-ST-segment elevation myocardial infarction was substantially higher in patients with RD compared with patients with normal renal function (31% versus 13%, P<0.001). Using hs-cTnT, patients with RD had comparable sensitivity of rule-out (100.0% [95% confidence interval {CI}, 97.6-100.0] versus 99.2% [95% CI, 97.6-99.8]; P=0.559), lower specificity of rule-in (88.7% [95% CI, 84.8-91.9] versus 96.5% [95% CI, 95.7-97.2]; P<0.001), and lower overall efficacy (51% versus 81%, P<0.001), mainly driven by a much lower percentage of patients eligible for rule-out (18% versus 68%, P<0.001) compared with patients with normal renal function. Using hs-cTnI, patients with RD had comparable sensitivity of rule-out (98.6% [95% CI, 95.0-99.8] versus 98.5% [95% CI, 96.5-99.5]; P=1.0), lower specificity of rule-in (84.4% [95% CI, 79.9-88.3] versus 91.7% [95% CI, 90.5-92.9]; P<0.001), and lower overall efficacy (54% versus 76%, P<0.001; proportion ruled out, 18% versus 58%, P<0.001) compared with patients with normal renal function. Conclusions: In patients with RD, the safety of the European Society of Cardiology 0/1-hour algorithm is high, but specificity of rule-in and overall efficacy are decreased. Modifications of the rule-in and rule-out thresholds did not improve the safety or overall efficacy of the 0/1-hour algorithm. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT00470587.